Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine GD Sanders, PJ Neumann, A Basu, DW Brock, D Feeny, M Krahn, ... Jama 316 (10), 1093-1103, 2016 | 2256 | 2016 |
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling JV Terza, A Basu, PJ Rathouz Journal of health economics 27 (3), 531-543, 2008 | 1715 | 2008 |
Continuous glucose monitoring and intensive treatment of type 1 diabetes Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group New England Journal of Medicine 359 (14), 1464-1476, 2008 | 1690 | 2008 |
Cost-effectiveness in health and medicine PJ Neumann, GD Sanders, LB Russell, JE Siegel, TG Ganiats Oxford University Press, 2016 | 1097 | 2016 |
Generalized modeling approaches to risk adjustment of skewed outcomes data WG Manning, A Basu, J Mullahy Journal of health economics 24 (3), 465-488, 2005 | 840 | 2005 |
Projecting the future diabetes population size and related costs for the US ES Huang, A Basu, M O'Grady, JC Capretta Diabetes Care 32 (12), 2225-2229, 2009 | 509 | 2009 |
Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis DD Kim, A Basu Value in Health 19 (5), 602-613, 2016 | 448 | 2016 |
Estimating marginal and incremental effects on health outcomes using flexible link and variance function models A Basu, PJ Rathouz Biostatistics 6 (1), 93-109, 2005 | 372 | 2005 |
Defining elements of value in health care—a health economics approach: an ISPOR Special Task Force report [3] DN Lakdawalla, JA Doshi, LP Garrison Jr, CE Phelps, A Basu, ... Value in Health 21 (2), 131-139, 2018 | 360 | 2018 |
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures W Yin, A Basu, JX Zhang, A Rabbani, DO Meltzer, GC Alexander Annals of internal medicine 148 (3), 169-177, 2008 | 249 | 2008 |
Use of instrumental variables in the presence of heterogeneity and self‐selection: an application to treatments of breast cancer patients A Basu, JJ Heckman, S Navarro‐Lozano, S Urzua Health economics 16 (11), 1133-1157, 2007 | 210 | 2007 |
Use of instrumental variables in the presence of heterogeneity and self-selection: an application in breast cancer patients A Basu, JJ Heckman, S Navarro-Lozano, S Urzua | 210* | 2006 |
Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence BJ Borah, A Basu Health economics 22 (9), 1052-1070, 2013 | 198 | 2013 |
Comparing alternative models: log vs Cox proportional hazard? A Basu, WG Manning, J Mullahy Health economics 13 (8), 749-765, 2004 | 198 | 2004 |
Protective and vulnerability factors predicting new-onset depressive episode in a representative of US adolescents BW Van Voorhees, D Paunesku, SA Kuwabara, A Basu, J Gollan, ... Journal of Adolescent Health 42 (6), 605-616, 2008 | 195 | 2008 |
Protective and vulnerability factors predicting new-onset depressive episode in a representative of US adolescents BW Van Voorhees, D Paunesku, SA Kuwabara, A Basu, J Gollan, ... Journal of Adolescent Health 42 (6), 605-616, 2008 | 195 | 2008 |
Value of information on preference heterogeneity and individualized care A Basu, D Meltzer Medical Decision Making 27 (2), 112-127, 2007 | 178 | 2007 |
Comparative cost analysis of housing and case management program for chronically ill homeless adults compared to usual care A Basu, R Kee, D Buchanan, LS Sadowski Health services research 47 (1 Pt 2), 523, 2012 | 167 | 2012 |
Issues for the next generation of health care cost analyses A Basu, WG Manning Medical care 47 (7_Supplement_1), S109-S114, 2009 | 166 | 2009 |
Risk stratification for sudden cardiac death: a plan for the future JJ Goldberger, A Basu, R Boineau, AE Buxton, ME Cain, JM Canty Jr, ... Circulation 129 (4), 516-526, 2014 | 165 | 2014 |